Ovarian steroids and raloxifene prevent MPTP-induced dopamine depletion in mice

NeuroReport

Volumn 11, Issue 2, 2000, Pages 343-346

  Grandbois, Michelle ^a,b   Morissette, Marc ^a,b   Callier, Sophie ^a,b,c   Di Paolo, Thérèse ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c HÔPITAL SAINT ANTOINE   (France)

Author keywords

Dopamine; Estradiol; Mice; MPTP; Parkinson's disease; Progesterone; Raloxifene; Steroids

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 3,4 DIHYDROXYPHENYLACETIC ACID; DOPAMINE; ESTRADIOL; HOMOVANILLIC ACID; PROGESTERONE; RALOXIFENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DOPAMINE BRAIN LEVEL; DRUG EFFECT; DRUG EFFICACY; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; STEREOSPECIFICITY;

EID: 0033968926     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-200002070-00024     Document Type: Article

References (25)

1. 1. McEwen BS, Alves SE, Bulloch K et al. Neurology 48(5 suppl 17), S8-S15 (1997).
2. 2. Di Paolo T. Rev Neurosci 5, 27-41 (1994).
3. 3. Sawada H, Ibi M, Kihara T et al. J Neurosci Res 54, 707-719 (1998).
4. 4. Behl C, Widmann M, Trapp T et al. Biochem Biophys Res Commun 216, 473-482 (1995).
5. 5. Inestrosa NC, Marzolo M-P and Bonnefont AB. Mol Neurobiol 17, 73-86 (1998).
6. 6. Marder K, Tang MX, Mejia H et al. Neurology 47, 155-160 (1996).
7. 7. Lyons KE, Bubble JP, Tröster AI et al. Clin Neuropharmacol 21, 118-121 (1998).
8. 8. Saunders-Pullman R, Gordon-Elliot J, Parides M et al. Neurology 52, 1417-1421 (1999).
9. 9. Grese TA and Dodge JA. Curr Pharm Des 4, 71-92 (1998).
10. 10. Lozano AM, Lang AE, Hutchison WD et al. Curr Opin Neurobiol 8, 783-790 (1998).
11. 11. Simon DK and Standaert DG. Med Clin North Am 83, 509-523 (1999).
12. 12. Dluzen DE, McDermott JL and Liu B. Neurotoxicol Teratol 18, 603-606 (1996).
13. 13. Miller DB, Ali SF, O'Callaghan JP et al. Ann N Y Acad Sci 844, 153-165 (1998).
14. 14. Delmas PD, Bjarnason NH, Mitlak BH et al. N Engl J Med 337, 1641-1647 (1997).
15. 15. Franklin K and Paxinos G. The Mouse Brain in Stereotaxic Coordinates. San Diego: Academic Press, 1997.
16. 16. Di Paolo T, Rouillard C and Bedard P. Eur J Pharmacol 117,197-203 (1985).
17. 17. Chowen JA, Torres-Aleman I and Garcia-Segura LM. Neuroendocrinology 56, 895-901 (1992).
18. 18. Laflamme N, Nappi RE, Drolet G et al. J Neurobiol 36, 357-378 (1998).
19. 19. Kritzer MF. J Comp Neurol 379, 247-260 (1997).
20. 20. Behl C, Skutella T, Lezoualc'h F et al. Mol Pharmacol 51, 535-541 (1997).
21. 21. Roof RL, Hoffman SW and Stein DG. Mol Chem Neuropathol 31, 1-11 (1997).
22. 22. Asbury ET, Fritts ME, Horton JE et al. Behav Brain Res 97, 99-106 (1998).
23. 23. Yang L, Matthews RT, Schulz JB et al. J Neurosa 18, 8145-8152 (1998).
24. 24. Garcia-Segura LM, Cardona-Gomez P, Naftolin F et al. Neuroreport 9, 593-597 (1998).
25. 25. Vegeto E, Pollio G, Pellicciari C et al. FASEB J 13, 793-803 (1999).